Vicagrel and its Impurities

Vicagrel is an oral antiplatelet agent developed to prevent thrombotic cardiovascular events by inhibiting platelet aggregation through P2Y12 receptor blockade. Reference standards of Vicagrel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 2 results for Vicagrel Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 22 1270000

Vicagrel

Vicagrel


  • Catalogue No.:PA 22 1270000

  • CAS :

    1314081-53-2

  • Molecular Formula : C18H18ClNO4S

  • Molecular Weight : 379.86

Drug Reference Standards & Impurity Synthesis in India
PA STI 090156

(S)-2-(2-Acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl-3,4,5,6-d4)acetic Acid

(S)-2-(2-Acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl-3,4,5,6-d4)acetic Acid


  • Catalogue No.:PA STI 090156

  • CAS :

    NA

  • Molecular Formula : C17H12D4ClNO4S

  • Molecular Weight : 369.85

pharmaffiliates